Author

Alba Dalmases

Hospital Del Mar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Beatríz BellosilloiD· 1 shared Carla Daniela Robles‐EspinozaiD· 1 shared Clara O. MontagutiD· 1 shared Constantine AlifrangisiD· 1 shared Francesco IorioiD· 1 shared Graham R. Bignell· 1 shared Iñigo MartincorenaiD· 1 shared Jamie YoungiD· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Beatríz BellosilloORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations.

Jonathan S. Brammeld, Mia Petljak, Iñigo Martincorena, Steven P. Williams, Luz García‐Alonso, Alba Dalmases, Beatríz Bellosillo, Carla Daniela Robles‐Espinoza, Stacey Price, Syd Barthorpe, Patrick S. Tarpey, Constantine Alifrangis, Graham R. Bignell, Joana Vidal, Jamie Young, , Ultan McDermott

This paper describes a method to identify drug resistance mutations in cancer using genome-wide chemical mutagenesis and next-generation sequencing, enabling the discovery of both known and novel resistance mechanisms.

Genome Research · Apr 1, 2017Peer-reviewedGenetics